Lv21
146 积分 2025-04-28 加入
Beyond the quick win: rebuilding the foundations of cancer immunotherapy
4小时前
求助中
In Situ Tracking of Membrane HER2 - Antibody–Drug Conjugate Interaction with Surface Plasmon Resonance Imaging
7天前
已完结
Epitope Binning of Monoclonal and Polyclonal Antibodies by Biolayer Interferometry
8天前
已完结
Exploring the intricacies of antigen–antibody interfaces: Effects of binding-induced conformational changes and distinct interaction patterns
1个月前
已完结
Cross-priming underlies the efficacy of antibody–drug conjugates and immunotherapy combinations
1个月前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
2个月前
已完结
Management of adverse events associated with TROP2-targeted antibody-drug conjugates in cancer patients
3个月前
已完结
An Update on Patent issues regarding Antibody Drug Conjugates
3个月前
已完结
Expanding access to cancer immunotherapy: A systematic review of low-dose PD-(L)1 inhibitor strategies
3个月前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
3个月前
已完结
皖公网安备34019202002308
